Developing a lyophilized cell-free biosensor for rapid diagnostics of clinical Pseudomonas aeruginosa infections
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    [Objective] Pseudomonas aeruginosa is a Gram-negative bacterium prevalent that is conditionally pathogenic and commonly associated with nosocomial infections. Its quorum sensing signal, 3-oxo-dodecanoyl-homoserine lactone (3OC12-HSL), has been reported as a biomarker for its infection. Here, we aimed to develop a 3OC12-HSL biosensor for facilitating rapid diagnostics of clinical P. aeruginosa infections. [Methods] We constructed a reporter plasmid responsive to 3OC12-HSL and prepared a lyophilized cell-free biosensor based on that plasmid. We characterized the biosensor with 3OC12-HSL concentration gradient, validated its utility by testing clinical samples, and attempted to optimize the preprocessing procedure for clinical samples.[Results] Our cell-free biosensor is sensitive, specific, and capable of diagnosing P. aeruginosa infections in clinical respiratory samples within 60 min.[Conclusion] In this study, we developed a lyophilized cell-free 3OC12-HSL biosensor. By pre-expressing RNase inhibitor, we increased our biosensor's tolerance to body fluid, and further demonstrated its potential to be developed as a rapid diagnostic method for clinical P. aeruginosa infections.

    Reference
    Related
    Cited by
Get Citation

HUANG Huiwen, YU Dingchen, LI Yirong, LIU Tiangang. Developing a lyophilized cell-free biosensor for rapid diagnostics of clinical Pseudomonas aeruginosa infections. [J]. Acta Microbiologica Sinica, 2023, 63(5): 1959-1969

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 14,2023
  • Revised:April 20,2023
  • Adopted:
  • Online: May 22,2023
  • Published: May 04,2023
Article QR Code